UBS O'Connor’s Clorox CLX Stock Holding History

UBS O'Connor’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-100,000	Closed	-$35K	–	643
2014 Q3	$35K	Buy	100,000 +55,000	+122%	+$4.97M	﹤0.01%	435
2014 Q2	$11K	Buy	+45,000	New	+$4.03M	﹤0.01%	425

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS O'Connor's CLX Position: Q1 2016 in Review

UBS O'Connor sold out of Clorox (CLX) in Q1 2016, closing a stake of 18,075 shares — an estimated $2.29M sold.

UBS O'Connor first reported a position in CLX in Q4 2014 and held it in 4 quarters. The position peaked at $8.11M in Q1 2015. 853 funds tracked by Wall St. Rank hold CLX as of Q1 2016.

UBS O'Connor reported no remaining Clorox position as of Q1 2016 after selling out during the quarter.
UBS O'Connor sold 18,075 Clorox shares in Q1 2016, an estimated $2.29M.
UBS O'Connor first reported a position in Clorox in Q4 2014 and held it in 4 quarters.
UBS O'Connor's Clorox position peaked at $8.11M in Q1 2015.
853 funds tracked by Wall St. Rank held Clorox as of Q1 2016.

Based on UBS O'Connor's 13F filing for Q1 2016, filed 13 May 2016.